Reading Time: 4 minutesOn 22 September 2014 Neuralstem announced the results from their long-term follow up of three participants who were involved in their initial phase I safety
Tag: clinical trials
Reading Time: 4 minutesA number of articles were published in various news sources on 11 July 2014, highlighting how scientists in Sheffield are working towards testing a promising
Reading Time: 4 minutesLast month the UK Government’s Department of Health announced an Early Access to Medicines Scheme. But, what is this new scheme? and what does it
Reading Time: 2 minutesA packed room at the 24th International Symposium on ALS/MND was given a fascinating whistle stop tour covering stem cells, robots and cellular garbage clearing,
Reading Time: 3 minutesResults from a phase I clinical trial of a drug known as ISIS 333611 have been published open-access online in the scientific journal Lancet Neurology on
Reading Time: 4 minutesAt this time of year, it’s always good to look back on the previous year to see just how far we’ve really come. We’re pleased
Reading Time: 3 minutesA very much ‘must report on’ session of the 23rd International Symposium on ALS/MND was the clinical trials and trial design session. There are many
Reading Time: 2 minutesYesterday, we announced on our website the disappointing news that the UK-based lithium clinical trial showed that lithium carbonate is ineffective at treating MND. Commenting
Reading Time: 3 minutesYesterday’s announcement by the biotechnology company Trophos SA of the lack of effectiveness of their compound olesoxime adds to the long list of drugs that
Reading Time: 3 minutes“After a time where patients and sponsors of trials alike had become disheartened about the lack of positive clinical trials, it is exciting to see